The Signaling Pathways and Targets of Natural Compounds from Traditional Chinese Medicine in Treating Ischemic Stroke

Ischemic stroke (IS) is a common neurological disorder associated with high disability rates and mortality rates. At present, recombinant tissue plasminogen activator (r-tPA) is the only US(FDA)-approved drug for IS. However, due to the narrow therapeutic window and risk of intracerebral hemorrhage,...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xing-Hua, Yin, Feng-Ting, Zhou, Xiao-Hang, Zhang, Ai-Hua, Sun, Hui, Yan, Guang-Li, Wang, Xi-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148018/
https://www.ncbi.nlm.nih.gov/pubmed/35630576
http://dx.doi.org/10.3390/molecules27103099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148018/
https://www.ncbi.nlm.nih.gov/pubmed/35630576
http://dx.doi.org/10.3390/molecules27103099

Ejemplares similares